NO20006008L - Fettsyreanaloger for behandling av inflammatoriske og autoimmune sykdommer - Google Patents
Fettsyreanaloger for behandling av inflammatoriske og autoimmune sykdommerInfo
- Publication number
- NO20006008L NO20006008L NO20006008A NO20006008A NO20006008L NO 20006008 L NO20006008 L NO 20006008L NO 20006008 A NO20006008 A NO 20006008A NO 20006008 A NO20006008 A NO 20006008A NO 20006008 L NO20006008 L NO 20006008L
- Authority
- NO
- Norway
- Prior art keywords
- fatty acid
- acid analogues
- inflammatory
- treatment
- autoimmune diseases
- Prior art date
Links
- 235000014113 dietary fatty acids Nutrition 0.000 title abstract 2
- 229930195729 fatty acid Natural products 0.000 title abstract 2
- 239000000194 fatty acid Substances 0.000 title abstract 2
- 150000004665 fatty acids Chemical class 0.000 title abstract 2
- 208000027866 inflammatory disease Diseases 0.000 title abstract 2
- 208000023275 Autoimmune disease Diseases 0.000 title 1
- 230000002757 inflammatory effect Effects 0.000 title 1
- IPBCWPPBAWQYOO-UHFFFAOYSA-N 2-(tetradecylthio)acetic acid Chemical compound CCCCCCCCCCCCCCSCC(O)=O IPBCWPPBAWQYOO-UHFFFAOYSA-N 0.000 abstract 1
- LUQGQZIVDLUXLE-UHFFFAOYSA-N CCCCCCCCCCCCCCCC(O)=[Se] Chemical compound CCCCCCCCCCCCCCCC(O)=[Se] LUQGQZIVDLUXLE-UHFFFAOYSA-N 0.000 abstract 1
- 241000124008 Mammalia Species 0.000 abstract 1
- 201000009594 Systemic Scleroderma Diseases 0.000 abstract 1
- 208000004732 Systemic Vasculitis Diseases 0.000 abstract 1
- 206010042953 Systemic sclerosis Diseases 0.000 abstract 1
- 206010047115 Vasculitis Diseases 0.000 abstract 1
- 201000001981 dermatomyositis Diseases 0.000 abstract 1
- 208000005987 polymyositis Diseases 0.000 abstract 1
- 206010039073 rheumatoid arthritis Diseases 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 201000000596 systemic lupus erythematosus Diseases 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/04—Drugs for disorders of the muscular or neuromuscular system for myasthenia gravis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/14—Drugs for disorders of the endocrine system of the thyroid hormones, e.g. T3, T4
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/38—Drugs for disorders of the endocrine system of the suprarenal hormones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Epidemiology (AREA)
- Diabetes (AREA)
- Physical Education & Sports Medicine (AREA)
- Neurology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Biomedical Technology (AREA)
- Rheumatology (AREA)
- Cardiology (AREA)
- Neurosurgery (AREA)
- Endocrinology (AREA)
- Hematology (AREA)
- Emergency Medicine (AREA)
- Communicable Diseases (AREA)
- Heart & Thoracic Surgery (AREA)
- Oncology (AREA)
- Vascular Medicine (AREA)
- Hospice & Palliative Care (AREA)
- Urology & Nephrology (AREA)
- Dermatology (AREA)
- Pulmonology (AREA)
- Psychiatry (AREA)
- Obesity (AREA)
- Virology (AREA)
- Transplantation (AREA)
Priority Applications (21)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| NO20006008A NO20006008L (no) | 2000-11-28 | 2000-11-28 | Fettsyreanaloger for behandling av inflammatoriske og autoimmune sykdommer |
| JP2002545699A JP4368579B2 (ja) | 2000-11-28 | 2001-11-27 | 炎症障害および自己免疫障害の治療用の脂肪酸アナログ |
| CA2457925A CA2457925C (en) | 2000-11-28 | 2001-11-27 | Fatty acid analogues for the treatment of inflammatory and autoimmune disorders |
| PCT/NO2001/000470 WO2002043728A1 (en) | 2000-11-28 | 2001-11-27 | Fatty acid analogues for the treatment of inflammatory and autoimmune disorders |
| AT01998347T ATE432071T1 (de) | 2000-11-28 | 2001-11-27 | Fettsäureanaloge zur behandlung von entzündungs- und autoimmunerkrankungen |
| KR1020037007097A KR100905335B1 (ko) | 2000-11-28 | 2001-11-27 | 염증성 및 자가 면역성 장애를 치료하기 위한 지방산 동족체 |
| ES01998347T ES2326159T3 (es) | 2000-11-28 | 2001-11-27 | Analogos de acidos grasos para el tratamiento de enfermedades inflamatorias y autoinmunes. |
| EP01998347A EP1351672B1 (en) | 2000-11-28 | 2001-11-27 | Fatty acid analogues for the treatment of inflammatory and autoimmune disorders |
| NZ525889A NZ525889A (en) | 2000-11-28 | 2001-11-27 | Fatty acid analogues for the treatment of inflammatory and autoimmune disorders |
| AU2002223162A AU2002223162B2 (en) | 2000-11-28 | 2001-11-27 | Fatty acid analogues for the treatment of inflammatory and autoimmune disorders |
| BR0115527-0A BR0115527A (pt) | 2000-11-28 | 2001-11-27 | Análogos de ácido graxo para o tratamento de distúrbios imflamatórios e autoimunes |
| HK05106536.3A HK1073793B (en) | 2000-11-28 | 2001-11-27 | Fatty acid analogues for the treatment of inflammatory and autoimmune disorders |
| MXPA03004427A MXPA03004427A (es) | 2000-11-28 | 2001-11-27 | Analogos de acido graso para el tratamiento de desordenes inflamatorios y autoinmunes. |
| US10/416,378 US8088825B2 (en) | 2000-11-28 | 2001-11-27 | Fatty acid analogues for the treatment of inflammatory and autoimmune disorders |
| RU2003115423/15A RU2259823C2 (ru) | 2000-11-28 | 2001-11-27 | Аналоги жирных кислот для лечения воспалительных и аутоиммунных расстройств |
| DE60138834T DE60138834D1 (de) | 2000-11-28 | 2001-11-27 | Fettsäureanaloge zur behandlung von entzündungs- und autoimmunerkrankungen |
| AU2316202A AU2316202A (en) | 2000-11-28 | 2001-11-27 | Fatty acid analogues for the treatment of inflammatory and autoimmune disorders |
| CNB018196969A CN1296039C (zh) | 2000-11-28 | 2001-11-27 | 治疗炎症和自身免疫性疾病的脂肪酸类似物 |
| NO20032054A NO324557B1 (no) | 2000-11-28 | 2003-05-08 | Anvendelse av fettsyreanaloger for a hindre og/eller behandle inflammatoriske og/eller autoimmune forstyrrelser. |
| ZA200303668A ZA200303668B (en) | 2000-11-28 | 2003-05-13 | Fatty acid analogues for the treatment of inflammatory and autoimmune disorders. |
| US13/340,157 US20120101161A1 (en) | 2000-11-28 | 2011-12-29 | Fatty acid analogues for the treatment of inflammatory and autoimmune disorders |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| NO20006008A NO20006008L (no) | 2000-11-28 | 2000-11-28 | Fettsyreanaloger for behandling av inflammatoriske og autoimmune sykdommer |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO20006008D0 NO20006008D0 (no) | 2000-11-28 |
| NO20006008L true NO20006008L (no) | 2002-05-29 |
Family
ID=19911849
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20006008A NO20006008L (no) | 2000-11-28 | 2000-11-28 | Fettsyreanaloger for behandling av inflammatoriske og autoimmune sykdommer |
Country Status (17)
| Country | Link |
|---|---|
| US (2) | US8088825B2 (no) |
| EP (1) | EP1351672B1 (no) |
| JP (1) | JP4368579B2 (no) |
| KR (1) | KR100905335B1 (no) |
| CN (1) | CN1296039C (no) |
| AT (1) | ATE432071T1 (no) |
| AU (2) | AU2316202A (no) |
| BR (1) | BR0115527A (no) |
| CA (1) | CA2457925C (no) |
| DE (1) | DE60138834D1 (no) |
| ES (1) | ES2326159T3 (no) |
| MX (1) | MXPA03004427A (no) |
| NO (1) | NO20006008L (no) |
| NZ (1) | NZ525889A (no) |
| RU (1) | RU2259823C2 (no) |
| WO (1) | WO2002043728A1 (no) |
| ZA (1) | ZA200303668B (no) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NO328803B1 (no) | 2000-03-03 | 2010-05-18 | Thia Medica | Nye fettsyreanaloger |
| CA2490121C (en) | 2002-06-20 | 2013-01-08 | Ic Vec Limited | Modified phospholipids |
| AU2005209331A1 (en) * | 2004-01-30 | 2005-08-11 | Peplin Biolipids Pty Ltd | Therapeutic and carrier molecules |
| KR20070054637A (ko) * | 2004-07-19 | 2007-05-29 | 티아 메디카 에이에스 | 식물유 및/또는 어유 및 비-산화성 지방산 구성요소를포함하는 조성물 |
| WO2009006668A1 (en) * | 2007-02-05 | 2009-01-15 | Children, Youth And Women's Health Service | Modulators of antigen-dependent t cell proliferation |
| DE102011050519A1 (de) * | 2011-05-20 | 2012-11-22 | Universität Rostock | Alkylschwefelalkansäurederivate und ihre pharmazeutisch verträglichen Salze zur Behandlung chronisch entzündlicher Erkrankungen |
| AU2014228387B2 (en) | 2013-03-11 | 2016-09-01 | Sciadonics, Inc. | Lipid compositions containing bioactive fatty acids |
| EP2968568A2 (en) | 2013-03-11 | 2016-01-20 | Life Science Nutrition AS | Natural lipids containing non-oxidizable fatty acids |
| EP3661600A4 (en) | 2017-10-23 | 2021-08-11 | Epitracker, Inc. | FATTY ACID ANALOGS AND ITS USE IN THE TREATMENT OF DISEASES RELATED TO METABOLISM SYNDROME |
| AU2019274431B2 (en) | 2018-05-23 | 2025-03-13 | Epitracker, Inc. | Compositions and methods for diagnosis and treatment of conditions related to the quality of aging and longevity |
| EP3908374A4 (en) | 2019-01-09 | 2022-12-28 | Epitracker, Inc. | COMPOSITIONS AND METHODS FOR THE DIAGNOSIS AND TREATMENT OF NEURODEGENERATIVE DISEASES |
| JP7404382B2 (ja) | 2019-03-04 | 2023-12-25 | エピトラッカー インコーポレイテッド | 脂肪酸アナログ、ならびに認知機能障害、行動症状および慢性疼痛の処置におけるそれらの使用 |
| WO2023080939A1 (en) | 2021-11-03 | 2023-05-11 | Epitracker, Inc. | Pentadecanoylcarnitine for treatment of conditions related to the quality of aging and longevity |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS56164120A (en) * | 1980-05-22 | 1981-12-17 | Chisso Corp | Antitumor agent |
| FR2631339B1 (fr) * | 1988-05-10 | 1990-11-16 | Cird | Nouveaux eicosanoides sulfures et leur application en pharmacie et en cosmetique |
| DE4120917A1 (de) * | 1991-06-25 | 1993-01-07 | Basf Ag | Ester von fettsaeuren mit aminoalkoholen zur verwendung bei der bekaempfung von krankheiten |
| US5807884A (en) * | 1992-10-30 | 1998-09-15 | Emory University | Treatment for atherosclerosis and other cardiovascular and inflammatory diseases |
| US5618955A (en) * | 1992-11-30 | 1997-04-08 | Yissum Research Development Company Of The Hebrew University Of Jerusalem | Fatty acid derivatives and pharmaceutical compositions containing same |
| IL103932A (en) | 1992-11-30 | 1997-02-18 | Yissum Res & Dev | Fatty acid and pharmaceutical compositions containing them |
| CN1088058C (zh) * | 1994-10-13 | 2002-07-24 | 肽技术有限公司 | 经修饰的多不饱和脂肪酸 |
| NO952796D0 (no) * | 1995-07-14 | 1995-07-14 | Rolf Berge | Fettsyre analoger med ikkeoksyderbart B-sete, fremstilling og anvendelse i krapeutiske preparater |
| RU2089179C1 (ru) * | 1995-12-14 | 1997-09-10 | Закрытое акционерное общество "ВАМ" | Стимулятор эндогенной продукции цитокинов и гепопоэтических факторов и способ его использования |
| WO1997038688A1 (en) * | 1996-04-12 | 1997-10-23 | Peptide Technology Pty. Limited | Methods of treating immunopathologies using polyunsaturated fattyacids |
| IL121165A0 (en) * | 1997-06-26 | 1997-11-20 | Yissum Res Dev Co | Pharmaceutical compositions containing carboxylic acids and derivatives thereof |
| AU7240398A (en) * | 1998-05-08 | 1999-11-29 | Rolf Berge | Use of non-beta-oxidizable fatty acid analogues for treatment of syndrome-x conditions |
| AUPQ291499A0 (en) | 1999-09-17 | 1999-10-07 | Women's And Children's Hospital Adelaide | Novel nitro and sulphur containing compounds |
-
2000
- 2000-11-28 NO NO20006008A patent/NO20006008L/no not_active Application Discontinuation
-
2001
- 2001-11-27 ES ES01998347T patent/ES2326159T3/es not_active Expired - Lifetime
- 2001-11-27 DE DE60138834T patent/DE60138834D1/de not_active Expired - Lifetime
- 2001-11-27 KR KR1020037007097A patent/KR100905335B1/ko not_active Expired - Fee Related
- 2001-11-27 NZ NZ525889A patent/NZ525889A/en unknown
- 2001-11-27 EP EP01998347A patent/EP1351672B1/en not_active Expired - Lifetime
- 2001-11-27 CA CA2457925A patent/CA2457925C/en not_active Expired - Fee Related
- 2001-11-27 CN CNB018196969A patent/CN1296039C/zh not_active Expired - Fee Related
- 2001-11-27 BR BR0115527-0A patent/BR0115527A/pt not_active IP Right Cessation
- 2001-11-27 US US10/416,378 patent/US8088825B2/en not_active Expired - Fee Related
- 2001-11-27 MX MXPA03004427A patent/MXPA03004427A/es active IP Right Grant
- 2001-11-27 AT AT01998347T patent/ATE432071T1/de not_active IP Right Cessation
- 2001-11-27 RU RU2003115423/15A patent/RU2259823C2/ru not_active IP Right Cessation
- 2001-11-27 JP JP2002545699A patent/JP4368579B2/ja not_active Expired - Fee Related
- 2001-11-27 AU AU2316202A patent/AU2316202A/xx active Pending
- 2001-11-27 AU AU2002223162A patent/AU2002223162B2/en not_active Ceased
- 2001-11-27 WO PCT/NO2001/000470 patent/WO2002043728A1/en not_active Ceased
-
2003
- 2003-05-13 ZA ZA200303668A patent/ZA200303668B/en unknown
-
2011
- 2011-12-29 US US13/340,157 patent/US20120101161A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| EP1351672B1 (en) | 2009-05-27 |
| BR0115527A (pt) | 2003-09-23 |
| HK1073793A1 (en) | 2005-10-21 |
| CA2457925C (en) | 2013-03-26 |
| US8088825B2 (en) | 2012-01-03 |
| CA2457925A1 (en) | 2002-06-06 |
| US20120101161A1 (en) | 2012-04-26 |
| MXPA03004427A (es) | 2004-05-04 |
| CN1633284A (zh) | 2005-06-29 |
| CN1296039C (zh) | 2007-01-24 |
| KR100905335B1 (ko) | 2009-07-01 |
| US20050165103A1 (en) | 2005-07-28 |
| EP1351672A1 (en) | 2003-10-15 |
| AU2002223162B2 (en) | 2006-11-30 |
| RU2259823C2 (ru) | 2005-09-10 |
| JP4368579B2 (ja) | 2009-11-18 |
| NZ525889A (en) | 2004-10-29 |
| ATE432071T1 (de) | 2009-06-15 |
| ZA200303668B (en) | 2004-01-30 |
| NO20006008D0 (no) | 2000-11-28 |
| DE60138834D1 (de) | 2009-07-09 |
| ES2326159T3 (es) | 2009-10-02 |
| AU2316202A (en) | 2002-06-11 |
| WO2002043728A1 (en) | 2002-06-06 |
| JP2004514693A (ja) | 2004-05-20 |
| KR20030055322A (ko) | 2003-07-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO20006008L (no) | Fettsyreanaloger for behandling av inflammatoriske og autoimmune sykdommer | |
| EA199800119A1 (ru) | Ингибиторы адгезии клеток | |
| EE05423B1 (et) | IL-18 inhibiitori kasutamine maksakahjustuse ja muude haiguste raviks v?i ennetamiseks sobiva ravimi valmistamiseks, vektori ja raku kasutamine inhibiitori produtseerimisel ning IL-18 inhibiitorit sisaldav farmatseutiline kompositsioon | |
| SG158733A1 (en) | Cell adhesion inhibitors | |
| CY1108706T1 (el) | Ανοσορυθμιστης | |
| EA199700135A1 (ru) | Ингибиторы клеточной адгезии | |
| DK1392329T3 (da) | Anvendelse af sulodexid til behandling af inflammatorisk tarmsygdom | |
| MA25809A1 (fr) | Derives d'arylmethylamine pour usage comme inhibiteurs de tryptase | |
| EP1983000A3 (en) | Method for the treatment of multiple sclerosis by inhibiting IL-17 activity | |
| ID29158A (id) | Monoester probukol untuk pengobatan penyakit kardiovaskular dan peradangan | |
| CY1107467T1 (el) | Χρηση οξεογονων υδρογονοτροφων στελεχων για την προληψη ή την αγωγη πεπτικων διαταραχων | |
| DE69434258D1 (de) | Mikroverkapselte 1,2-benzazole | |
| EE9900428A (et) | Köhavastased ravimkoostised | |
| SE9603725D0 (sv) | New teatment | |
| DE60131393D1 (de) | Verfahren zur behandlung von erkrankungen assoziiert mit akuten entzündung unter nichtischämischen zustände | |
| DE60140960D1 (de) | Verwendung von serp-1 in kombination mit einem immunosuppressor zur behandlung von arthritis | |
| DK1342410T3 (da) | Anvendelse af en galaninagonist til fremstilling af et medikament til forbedring af hukommelse og andre kognitive funktioner | |
| EA200300639A1 (ru) | Применение sarp-1 для лечения и/или предупреждения склеродермии | |
| BR0311248A (pt) | Kit de contracepção e/ou de hrt, usos de um éster de etonogestrel de ação prolongada, de um éster de etonogestrel de ação prolongada em conjunto com um éster de andrógeno de ação prolongada e de um éster de etonogestrel de ação prolongada em conjunto com um estrogênio, e, métodos de contracepção e /ou de hrt e de tratamento e/ou de prevenção de um distúrbio ginecológico feminino | |
| PT1392672E (pt) | Clorometilacao de tiofeno | |
| NO20032054D0 (no) | Fettsyreanaloger for behandling av inflammatoriske lidelser og autoimmune forstyrrelser | |
| ATE269095T1 (de) | Verfahren zur herstellung antitumoraler th1- zellen | |
| WO2025006568A3 (en) | Mk2 inhibitors and methods of making and using the same | |
| HUP0200354A2 (hu) | 15-Dezoxi-spergualin alkalmazása hiperreaktív gyulladásos betegségek és autoimmun betegségek kezelésére | |
| ATE345138T1 (de) | Verfahren und zusammensetzungen zur vorbeugung und behandlung von sodbrennen |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |